Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2012
12/19/2012CN101926788B Cardiovascular/cerebral and ophthalmological medicines, and preparation and use thereof
12/19/2012CN101914106B Cefamandole nafate hydrate and preparation method thereof
12/19/2012CN101910141B A novel alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
12/19/2012CN101897674B L-半胱氨酸片及其制备方法 L- cysteine ​​sheet and its preparation method
12/19/2012CN101885676B Reduced anthraquinone compound with antibacterial activity
12/19/2012CN101790514B 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof
12/19/2012CN101787063B Anti-infective medicament and preparation and application thereof
12/19/2012CN101732720B Preparation and application of anti-cancer medicament carrier with dual functions of targeting and fluorescence
12/19/2012CN101703537B Ephedra total polysaccharide extractive and preparation method and medical application thereof
12/19/2012CN101675921B Method for preparing potassium aspartape raw medicine by physical method and preparation thereof
12/19/2012CN101652128B Sustained release compositions using wax-like materials
12/19/2012CN101606913B Cefixime dispersing tablet and preparation methods thereof
12/19/2012CN101596159B New taxol injection and preparation method thereof
12/19/2012CN101588793B Method of forming a tablet comprising pre-blend of ibupropen and silicon dioxide
12/19/2012CN101574375B Lactobacillus health-care capsule and preparation method thereof
12/19/2012CN101574341B Oral solid medicine composition containing ropinirole
12/19/2012CN101549039B Application of schisandra fruit or related monomeric compound thereof for preventing or curing fatty liver
12/19/2012CN101538258B Compound of salvia miltiorrhiza and derivative, preparation method and medicine application thereof
12/19/2012CN101496789B Sitafloxacin sustained-release pellet and preparation method thereof
12/19/2012CN101481338B Synthesizing method and use of vanadium taurate
12/19/2012CN101474144B Tetracaine hydrochloride lipidosome gel and preparation method thereof
12/19/2012CN101454320B Pyridine[3,4-b]pyrazinones
12/19/2012CN101443330B Heterocycle non-nucleosides compound and preparation method thereof, medicament composition and purpose as antivirus antivirus inhibitor
12/19/2012CN101412740B Hydrate of azithromycin, and preparation and use thereof
12/19/2012CN101380356B Tibetan medicine Duyiwei total flavone extract and extraction method and use thereof
12/19/2012CN101129363B FK506 topical application sustained release film patch of immunosuppressive agent for accelerating regeneration of nerve, method of producing the same and use of the same
12/19/2012CN101115728B Triazole substituted aminobenzophenone compounds
12/19/2012CN101068794B Quinazolines useful as modulators of ion channels
12/18/2012US8334413 Topical compositions and methods for epithelial-related conditions
12/18/2012US8334408 Analogs of alpha galactosylceramide and uses thereof
12/18/2012US8334387 Method for measuring aromatase activity
12/18/2012US8334382 Substituted biaryl piperazinyl-pyridine analogues
12/18/2012US8334370 Polynucleotides comprising intercalating entities
12/18/2012US8334322 Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance
12/18/2012US8334321 Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent
12/18/2012US8334320 Methods for chelation therapy
12/18/2012US8334319 Polymorphic forms of oseltamivir phosphate
12/18/2012US8334318 Anionic isosorbide derivatives and their use (II)
12/18/2012US8334317 Calcium receptor modulating agents
12/18/2012US8334316 Substituted organosulfur compounds and methods of using thereof
12/18/2012US8334315 Substituted aromatic carboxamide and urea derivatives as vanilloid receptor ligands
12/18/2012US8334314 Phenylpropionic acid derivative and use thereof
12/18/2012US8334313 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
12/18/2012US8334311 Indoline anti-cancer agents
12/18/2012US8334310 Selective glycosidase inhibitors and uses thereof
12/18/2012US8334309 Heterocyclic indazole derivatives
12/18/2012US8334308 Renin inhibitors
12/18/2012US8334307 Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating proliferative diseases
12/18/2012US8334306 Nitroxide free radical synergized antineoplastic agents
12/18/2012US8334305 N-adamantyl benzamides as inhibitors of 11-β-hydroxysteroid dehydrogenase
12/18/2012US8334304 Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists
12/18/2012US8334303 Specifically mutilin 14-(exo-8-methyl-8-azabicyclo[3.2.1]oct-3-ylsulfanyl)-acetate (SB 268091); use as antibiotic; crystallization from isopropanol; improved bioavailability, and/or physical properties, for example solubility or flow properties
12/18/2012US8334302 Synthesis and anti-proliferative effect of substituted imidazo[4,5-b]pyridine compounds
12/18/2012US8334301 5-Membered heterocyclic compound
12/18/2012US8334299 β-carboline for the treatment of neurodegenerative diseases
12/18/2012US8334298 Treatment or prevention of ovarian hyperstimulation syndrome (OHSS) using a dopamine agonist
12/18/2012US8334297 2,4-pyrimidinediamine compounds for treatment of inflammatory disorders
12/18/2012US8334296 2,4-pyrimidinediamine compounds and their uses
12/18/2012US8334295 Pyrimidine derivatives as HIV reverse transcriptase inhibitors
12/18/2012US8334294 4,8-diphenyl-polyazanaphthalene derivatives
12/18/2012US8334293 P70 S6 kinase inhibitor and EGFR inhibitor combination therapy
12/18/2012US8334290 CETP inhibitors
12/18/2012US8334289 Pyridin-2-one compounds and their use as modulators of the dopamine D3 receptor
12/18/2012US8334288 4-phenoxymethylpiperidines as modulators of GPR119 activity
12/18/2012US8334287 Imidazoles
12/18/2012US8334286 Substituted pyrrolo[1,2-A] pyrazines, compositions containing these, processes of making these, and uses thereof
12/18/2012US8334284 Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders
12/18/2012US8334283 Compositions and methods for treating, reducing, ameliorating, or preventing infections
12/18/2012US8334282 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
12/18/2012US8334281 Nasal formulations of metoclopramide
12/18/2012US8334280 Ligands of estrogen receptors α and β, method of their preparation, and pharmaceuticals comprising them
12/18/2012US8334279 Non-hormonal steroid modulators of NF-κB for treatment of disease
12/18/2012US8334278 Use of 3-methoxy-pregnenolone for the preparation of a drug for treating depressive disorders and long-term neurological diseases
12/18/2012US8334277 {4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenoxy}phosphate or a pharmaceutically acceptable salt thereof, a production method therefor and a pharmaceutical composition for preventing and treating central nervous system disorders containing the same as an active component
12/18/2012US8334276 Cystitis treatment with high dose chondroitin sulfate
12/18/2012US8334273 Compositions and methods for inhibiting expression of factor VII gene
12/18/2012US8334272 Methods for nucleic acid transfer into cells
12/18/2012US8334270 Nucleoside phosphoramidate prodrugs
12/18/2012US8334269 Composition comprising Xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof
12/18/2012US8334268 Insecticidal active ingredient combinations (formononetins + insecticides)
12/18/2012US8334267 Mangiferin calcium salts, the method for its preparation and its use
12/18/2012US8334263 Analgesic methods and compositions
12/18/2012US8334262 Cognitive function
12/18/2012US8334248 Aqueous solution of olanexidine, method of preparing the aqueous solution, and disinfectant
12/18/2012US8334000 Anti-angiogenic extracts from pomegranate
12/18/2012US8333992 Gastric retained gabapentin dosage form
12/18/2012US8333991 Gastric retained gabapentin dosage form
12/18/2012US8333990 Solid pharmaceutical dosage form
12/18/2012US8333987 Nourexin-4 nano-lipid emulsions
12/18/2012US8333982 Aqueous microemulsions containing organic insecticide compounds
12/18/2012US8333976 Processes for inhibiting development of allergic disease
12/18/2012US8333962 Controlled release multidrug formulations for spinal cord injury
12/18/2012US8333961 Natural liniment for treatment of skin cancers
12/18/2012US8333957 Liquid deodorant composition and deodorizing method
12/18/2012US8333955 High viscosity oil, medium viscosity oil, and low viscosity oil; and an oily gelling agent comprising an ester of glycerol or polyglycerin with an aliphatic or hydroxyl aliphatic acid and a dibasic acid; gloss, shape retention; lipsticks
12/18/2012US8333954 Foamable sanitizing compositions
12/18/2012US8333192 Dry powder comprising levothyroxine sodium administrated via inhalator
12/18/2012CA2754102C Monoclonal antibodies and compositions comprising such useful for inhibition of .alpha.v.beta.5 mediated angiogenesis
12/18/2012CA2720944C Compounds and compositions as kinase inhibitors
12/18/2012CA2719721C Tetrahydroisoquinoline derivative
1 ... 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 ... 7860